Hancock Jaffe Laboratories Inc. (HJLI) shares are trading at higher $0.56 and the avg recommendation for the stock is Moderate Buy.
To add more color to this target, the company’s high over the last year is $1.01 and the low is $0.21. Over the last 52 weeks, HJLI is down -41.86% while the S&P 500 is up 10.88%. The catalyst for this interesting swing was the company’s recent earnings report.
A Notable Earnings Report
HJLI Return on Equity (ROE) is -622.50%, and its Return on Assets is -175.70%. All told, it is clear that, HJLI needs to be on your watchlist.
Find out when HJLI reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. HJLI has a short ratio of 0.18 and outstanding shares of 21.46M.
HJLI has seen increased volume after this news and investors are putting their support behind the value proposition. Traders will also note the company’s earnings per share came in at -0.37. Hancock Jaffe Laboratories Inc. HJLI also noted assets of $3.73 million at the end of the last quarter. Investors should also keep an eye on sector updates as HJLI has historically followed its peers on positive news.
All told, Hancock Jaffe Laboratories Inc. HJLI has strung together solid data and demonstrated underlying fundamentals. At its current valuation, HJLI represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.
Hancock Jaffe Laboratories Inc. HJLI is now commanding a market cap of 15.70M and a float of 18.19M. HJLI is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of HJLI stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in HJLI, either long or short, and we have not been compensated for this article.